Ordopidine

Ordopidine

SCHEMBL2370525

CCN1CCC(c2cccc(S(C)(=O)=O)c2F)CC1.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD2

The experimentally established mechanism targets of Ordopidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 5/20 0.41
DRD3 P35462 4/20 0.46
HTR6 P50406 4/20 0.46
HRH3 Q9Y5N1 2/20 0.46
SIGMAR1 Q99720 1/20 0.41
SLC6A4 P31645 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NSD2 O96028 1/20 0.38
SLC9A1 P19634 1/20 0.36
HCRTR2 O43614 2/20 0.36
KDM2B Q8NHM5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ordopidine SCHEMBL30522152 1.00 DRD3 (0.46) DRD3HTR6HRH3DRD2SIGMAR1
Ordopidine SCHEMBL2370600 0.99 DRD3 (0.47) DRD3HTR6HRH3DRD2SIGMAR1
SCHEMBL13304588 0.94 DRD3 (0.44) DRD3HTR6HRH3DRD2SIGMAR1
SCHEMBL2783233 0.88 DRD2 (0.55) DRD3HTR6DRD2SIGMAR1SLC6A4
SCHEMBL13815538 0.86 SIGMAR1 (0.47) DRD3HTR6DRD2SIGMAR1SLC6A4
Ordopidine SCHEMBL5506147 0.85 HTR6 (0.38) DRD3HTR6HRH3DRD2SIGMAR1
SCHEMBL2783693 0.85 KDM4E (0.38) DRD3HTR6HRH3DRD2SIGMAR1
SCHEMBL2784849 0.85 DRD3 (0.45) DRD3HTR6HRH3DRD2SIGMAR1
SCHEMBL2783821 0.85 DRD3 (0.45) DRD3HTR6HRH3DRD2SLC6A4
SCHEMBL2781820 0.84 HTR6 (0.48) DRD3HTR6HRH3DRD2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011107583-A1 SUBSTITUTED 4-PHENYL-N-ALKYL-PIPERIDINES FOR PREVENTING ONSET OR SLOWING PROGRESSION OF NEURODEGENERATIVE DISORDERS NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2011-09-09 WO claimed
WO-2011107583-A1 SUBSTITUTED 4-PHENYL-N-ALKYL-PIPERIDINES FOR PREVENTING ONSET OR SLOWING PROGRESSION OF NEURODEGENERATIVE DISORDERS NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2011-09-09 WO disclosed